Alejandro Sanchez

Summary

Affiliation: University of Southern California
Country: USA

Publications

  1. ncbi request reprint Emerging fungal pathogens in pulmonary disease
    Alejandro Sanchez
    University of Southern California, Division of Infectious Diseases, Los Angeles, California 90033, USA
    Curr Opin Pulm Med 13:199-204. 2007
  2. pmc Relationship of Acute Phase Reactants and Fat Accumulation during Treatment for Tuberculosis
    Alejandro Sanchez
    Division of Infectious Diseases, Department of Medicine, The Keck School of Medicine and the School of Pharmacy of the University of Southern California, IRD Building, Room 432, 2020 Zonal Avenue, Los Angeles, CA 90033, USA
    Tuberc Res Treat 2011:346295. 2011
  3. pmc Correspondence of in vitro and in vivo fluconazole dose-response curves for Cryptococcus neoformans
    Robert A Larsen
    Department of Medicine Infectious Diseases, 2020 Zonal Ave, IRD Room 620, MC 9520, University of Southern California, Los Angeles, CA 90033, USA
    Antimicrob Agents Chemother 49:3297-301. 2005

Detail Information

Publications3

  1. ncbi request reprint Emerging fungal pathogens in pulmonary disease
    Alejandro Sanchez
    University of Southern California, Division of Infectious Diseases, Los Angeles, California 90033, USA
    Curr Opin Pulm Med 13:199-204. 2007
    ..Invasive fungal infections of the lung have been increasing due to the increase of the population most at risk. This review aims to describe some of the emerging fungal pathogens and their complex management...
  2. pmc Relationship of Acute Phase Reactants and Fat Accumulation during Treatment for Tuberculosis
    Alejandro Sanchez
    Division of Infectious Diseases, Department of Medicine, The Keck School of Medicine and the School of Pharmacy of the University of Southern California, IRD Building, Room 432, 2020 Zonal Avenue, Los Angeles, CA 90033, USA
    Tuberc Res Treat 2011:346295. 2011
    ..CRP levels declined by ∼50% at each interval visit. Conclusions. During the initial treatment, acute phase reactants returned towards normal. The predominant accrual of fat mass probably reflects ongoing, low levels of inflammation...
  3. pmc Correspondence of in vitro and in vivo fluconazole dose-response curves for Cryptococcus neoformans
    Robert A Larsen
    Department of Medicine Infectious Diseases, 2020 Zonal Ave, IRD Room 620, MC 9520, University of Southern California, Los Angeles, CA 90033, USA
    Antimicrob Agents Chemother 49:3297-301. 2005
    ..In vitro antifungal drug susceptibility testing can reliably predict the murine response to fluconazole...